immunolog studi cystic fibrosi evid present support concept much allergi cystic fibrosi cf ige mediat total ige level higher allerg nonallerg cf patient level also higher patient greatest number chest infect preced 12 month ige antibodi level dermatophagoid pteronyssinu timothi grass pollen aspergillu fumigatu higher posit result skin test allergen serum igg igm iga level allerg nonallerg cf patient differ overal mean valu igg igm higher report healthi british children highest level tend present patient greatest number recent major chest infect differ signific igg 16 patient iga level 2 sd report mean agematch control 11 nonallerg iga level also higher patient recent experienc major chest infect 45 patient tissu type hla b antigen signific clinic associ singl antigen observ antigen phenotyp a1 b8 common patient multipl allerg symptom singl allergi mere posit result skin test nonsignific increas w19 patient frequent infect a2 patient present meconium ileu also note data present permit choic made altern concept allergi primari abnorm cf allergi aris secondari infect